Average Co-Inventor Count = 6.76
ph-index = 7
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Cymabay Therapeutics, Inc. (10 from 43 patents)
2. Metabolex, Inc. (9 from 41 patents)
3. Edison Pharmaceuticals, Inc. (2 from 28 patents)
4. Eli Lilly and Company (1 from 4,442 patents)
5. Johnson & Johnson Consumer Companies, Inc. (1 from 271 patents)
6. Galileo Pharmaceuticals, Inc. (1 from 9 patents)
24 patents:
1. 9925189 - Heterocyclic receptor agonists for the treatment of diabetes and metabolic disorders
2. 9737537 - Heterocyclic receptor agonists for the treatment of diabetes and metabolic disorders
3. 9593109 - Bicyclic agonists of GPR131 and uses thereof
4. 9150567 - Substituted tetrazol-1-yl-phenoxymethyl-thiazol-2-yl-piperidinyl-pyrimidine salts
5. 8975258 - Heterocyclic receptor agonists for the treatment of diabetes and metabolic disorders
6. 8921350 - Heterocyclic receptor agonists for the treatment of diabetes and metabolic disorders
7. 8912356 - DCC mediated coupling for halofenate manufacture
8. 8846675 - N-linked heterocyclic receptor agonists for the treatment of diabetes and metabolic disorders
9. 8815886 - Substituted tetrazol-1-yl-phenoxymethyl-thiazol-2-yl-piperidinyl-pyrimidine salts
10. 8703776 - Agonists of GPR131 and uses thereof
11. 8598374 - GPR120 receptor agonists and uses thereof
12. 8476308 - GPR120 receptor agonists and uses thereof
13. 8410127 - Substituted tetrazol-1-yl-phenoxymethyl-thiazol-2-yl-piperidinyl-pyrimidine salts
14. 8309600 - GPR120 receptor agonists and uses thereof
15. 8299117 - GPR120 receptor agonists and uses thereof